Nicolas SÉRÈS
Co-Founder & CEO @ WiSEED
Toulouse, France
Nicolas SÉRÈS is a seed investor at WiSEED in Toulouse focused on Life Science and Biotechnology. Nicolas SÉRÈS - Co-Founder & CEO @ WiSEED
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Nicolas SÉRÈS invests in
Stages Nicolas SÉRÈS invests in
Countries Nicolas SÉRÈS invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. Thecompany's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections.Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France. | Seed / Oct 01, 2012 |
About WiSEED
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
WiSEED Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Nicolas SÉRÈS
Co-Founder & CEO
|
|||
|
Stephanie SAVEL
President
|
|||
|
Thierry MERQUIOL
Co-Founder & Chairman of the board
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Nicolas SÉRÈS invest in?
Nicolas SÉRÈS invests primarily in Life Science, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nicolas SÉRÈS last invest?
The most recent investment recorded for Nicolas SÉRÈS closed in Oct 2012. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!